Decrease in Serum Adiponectin Levels in Response to Treatment Predicts Good Prognosis in Acute Decompensated Heart Failure

J Clin Hypertens (Greenwich). Adiponectin is a cardioprotective adipocytokine. Serum adiponectin concentration decreases in patients who are obese but increases in patients with chronic heart failure (CHF). The aim of this study was to explore the temporal changes in serum adiponectin concentration...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2010-11, Vol.12 (11), p.900-904
Main Authors: Matsumoto, Mika, Lee‐Kawabata, Masaaki, Tsujino, Takeshi, Naito, Yoshiro, Ezumi, Akira, Sakoda, Tsuyoshi, Ohyanagi, Mitsumasa, Shimomura, Iichiro, Masuyama, Tohru
Format: Article
Language:English
Subjects:
Acute Disease
Adiponectin - blood
Adipose Tissue - drug effects
Adipose Tissue - metabolism
Aged
Aged, 80 and over
Female
Follow-Up Studies
Heart Failure - drug therapy
Heart Failure - metabolism
Heart Failure - physiopathology
Hospitalization
Humans
Male
Middle Aged
Mortality
Original Papers
Predictive Value of Tests
Prognosis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5388-b0d584a9f82517de33f8186ab5bad0f572aad894edf7d5260753717bf35a2b3c3
cites cdi_FETCH-LOGICAL-c5388-b0d584a9f82517de33f8186ab5bad0f572aad894edf7d5260753717bf35a2b3c3
container_end_page 904
container_issue 11
container_start_page 900
container_title The journal of clinical hypertension (Greenwich, Conn.)
container_volume 12
creator Matsumoto, Mika
Lee‐Kawabata, Masaaki
Tsujino, Takeshi
Naito, Yoshiro
Ezumi, Akira
Sakoda, Tsuyoshi
Ohyanagi, Mitsumasa
Shimomura, Iichiro
Masuyama, Tohru
description J Clin Hypertens (Greenwich). Adiponectin is a cardioprotective adipocytokine. Serum adiponectin concentration decreases in patients who are obese but increases in patients with chronic heart failure (CHF). The aim of this study was to explore the temporal changes in serum adiponectin concentration following treatment for acute decompensated heart failure (ADHF). Serum adiponectin was measured on admission and at discharge in 95 patients who were admitted to our hospital with ADHF. Ten patients without heart failure (HF) served as controls. Serum adiponectin concentration was higher on admission in HF patients than in the controls (22.6±13.3 μg/mL vs 9.3±3.9 μg/mL, P
doi_str_mv 10.1111/j.1751-7176.2010.00368.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8816472</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>763176342</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5388-b0d584a9f82517de33f8186ab5bad0f572aad894edf7d5260753717bf35a2b3c3</originalsourceid><addsrcrecordid>eNqNUU1v3CAURFWr5qP9CxW3nLwBYwwrRZVW2yabaKVWbXpGGJ4TVrbZAk6T_vrgbLJqbuXCY97M8GAQwpTMaF6nmxkVnBaCinpWkowSwmo5u3-DDveNt7nmZVXUGTlARzFuCOGMzcl7dFBSwish5CH6-wVMAB0BuwH_hDD2eGHd1g9gUkbWcAddnHo_IGY085LH11mRehgS_h7AOpMivvDe5pO_GXx0T4KFGRPgbO_7LQxRJ7B4BTokfK5dNwb4gN61uovw8Xk_Rr_Ov14vV8X628XlcrEuDGdSFg2xXFZ63sqSU2GBsVZSWeuGN9qSlotSayvnFdhWWF7WRHCW39-0jOuyYYYdo8873-3Y9GBNnjvoTm2D63V4UF479bozuFt14--UlLSuRJkNTp4Ngv89Qkyqd9FA1-kB_BiVqFn-b1ZNTLljmuBjDNDub6FETcmpjZoCUlNAakpOPSWn7rP0079T7oUvUWXC2Y7wx3Xw8N_G6mq5ygV7BDOaqdI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>763176342</pqid></control><display><type>article</type><title>Decrease in Serum Adiponectin Levels in Response to Treatment Predicts Good Prognosis in Acute Decompensated Heart Failure</title><source>PubMed Central</source><creator>Matsumoto, Mika ; Lee‐Kawabata, Masaaki ; Tsujino, Takeshi ; Naito, Yoshiro ; Ezumi, Akira ; Sakoda, Tsuyoshi ; Ohyanagi, Mitsumasa ; Shimomura, Iichiro ; Masuyama, Tohru</creator><creatorcontrib>Matsumoto, Mika ; Lee‐Kawabata, Masaaki ; Tsujino, Takeshi ; Naito, Yoshiro ; Ezumi, Akira ; Sakoda, Tsuyoshi ; Ohyanagi, Mitsumasa ; Shimomura, Iichiro ; Masuyama, Tohru</creatorcontrib><description>J Clin Hypertens (Greenwich). Adiponectin is a cardioprotective adipocytokine. Serum adiponectin concentration decreases in patients who are obese but increases in patients with chronic heart failure (CHF). The aim of this study was to explore the temporal changes in serum adiponectin concentration following treatment for acute decompensated heart failure (ADHF). Serum adiponectin was measured on admission and at discharge in 95 patients who were admitted to our hospital with ADHF. Ten patients without heart failure (HF) served as controls. Serum adiponectin concentration was higher on admission in HF patients than in the controls (22.6±13.3 μg/mL vs 9.3±3.9 μg/mL, P&lt;.01). Serum adiponectin concentration decreased after treatment in HF patients (18.0±11.7 μg/mL vs 22.6±13.3 μg/mL, P&lt;.01). The larger temporal decrease in adiponectin level in ADHF was associated with the lower incidence of cardiac death or HF hospitalizations (log‐rank, P&lt;.05). Serum adiponectin concentration was elevated in ADHF and decreased following the treatment. How much serum adiponectin decreases in response to treatment in ADHF is an important determinant of the prognosis. J Clin Hypertens (Greenwich). 2010;12:900–904.</description><identifier>ISSN: 1524-6175</identifier><identifier>EISSN: 1751-7176</identifier><identifier>DOI: 10.1111/j.1751-7176.2010.00368.x</identifier><identifier>PMID: 21054778</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Acute Disease ; Adiponectin - blood ; Adipose Tissue - drug effects ; Adipose Tissue - metabolism ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Heart Failure - drug therapy ; Heart Failure - metabolism ; Heart Failure - physiopathology ; Hospitalization ; Humans ; Male ; Middle Aged ; Mortality ; Original Papers ; Predictive Value of Tests ; Prognosis</subject><ispartof>The journal of clinical hypertension (Greenwich, Conn.), 2010-11, Vol.12 (11), p.900-904</ispartof><rights>2010 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5388-b0d584a9f82517de33f8186ab5bad0f572aad894edf7d5260753717bf35a2b3c3</citedby><cites>FETCH-LOGICAL-c5388-b0d584a9f82517de33f8186ab5bad0f572aad894edf7d5260753717bf35a2b3c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816472/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816472/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21054778$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsumoto, Mika</creatorcontrib><creatorcontrib>Lee‐Kawabata, Masaaki</creatorcontrib><creatorcontrib>Tsujino, Takeshi</creatorcontrib><creatorcontrib>Naito, Yoshiro</creatorcontrib><creatorcontrib>Ezumi, Akira</creatorcontrib><creatorcontrib>Sakoda, Tsuyoshi</creatorcontrib><creatorcontrib>Ohyanagi, Mitsumasa</creatorcontrib><creatorcontrib>Shimomura, Iichiro</creatorcontrib><creatorcontrib>Masuyama, Tohru</creatorcontrib><title>Decrease in Serum Adiponectin Levels in Response to Treatment Predicts Good Prognosis in Acute Decompensated Heart Failure</title><title>The journal of clinical hypertension (Greenwich, Conn.)</title><addtitle>J Clin Hypertens (Greenwich)</addtitle><description>J Clin Hypertens (Greenwich). Adiponectin is a cardioprotective adipocytokine. Serum adiponectin concentration decreases in patients who are obese but increases in patients with chronic heart failure (CHF). The aim of this study was to explore the temporal changes in serum adiponectin concentration following treatment for acute decompensated heart failure (ADHF). Serum adiponectin was measured on admission and at discharge in 95 patients who were admitted to our hospital with ADHF. Ten patients without heart failure (HF) served as controls. Serum adiponectin concentration was higher on admission in HF patients than in the controls (22.6±13.3 μg/mL vs 9.3±3.9 μg/mL, P&lt;.01). Serum adiponectin concentration decreased after treatment in HF patients (18.0±11.7 μg/mL vs 22.6±13.3 μg/mL, P&lt;.01). The larger temporal decrease in adiponectin level in ADHF was associated with the lower incidence of cardiac death or HF hospitalizations (log‐rank, P&lt;.05). Serum adiponectin concentration was elevated in ADHF and decreased following the treatment. How much serum adiponectin decreases in response to treatment in ADHF is an important determinant of the prognosis. J Clin Hypertens (Greenwich). 2010;12:900–904.</description><subject>Acute Disease</subject><subject>Adiponectin - blood</subject><subject>Adipose Tissue - drug effects</subject><subject>Adipose Tissue - metabolism</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - metabolism</subject><subject>Heart Failure - physiopathology</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Original Papers</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><issn>1524-6175</issn><issn>1751-7176</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNUU1v3CAURFWr5qP9CxW3nLwBYwwrRZVW2yabaKVWbXpGGJ4TVrbZAk6T_vrgbLJqbuXCY97M8GAQwpTMaF6nmxkVnBaCinpWkowSwmo5u3-DDveNt7nmZVXUGTlARzFuCOGMzcl7dFBSwish5CH6-wVMAB0BuwH_hDD2eGHd1g9gUkbWcAddnHo_IGY085LH11mRehgS_h7AOpMivvDe5pO_GXx0T4KFGRPgbO_7LQxRJ7B4BTokfK5dNwb4gN61uovw8Xk_Rr_Ov14vV8X628XlcrEuDGdSFg2xXFZ63sqSU2GBsVZSWeuGN9qSlotSayvnFdhWWF7WRHCW39-0jOuyYYYdo8873-3Y9GBNnjvoTm2D63V4UF479bozuFt14--UlLSuRJkNTp4Ngv89Qkyqd9FA1-kB_BiVqFn-b1ZNTLljmuBjDNDub6FETcmpjZoCUlNAakpOPSWn7rP0079T7oUvUWXC2Y7wx3Xw8N_G6mq5ygV7BDOaqdI</recordid><startdate>201011</startdate><enddate>201011</enddate><creator>Matsumoto, Mika</creator><creator>Lee‐Kawabata, Masaaki</creator><creator>Tsujino, Takeshi</creator><creator>Naito, Yoshiro</creator><creator>Ezumi, Akira</creator><creator>Sakoda, Tsuyoshi</creator><creator>Ohyanagi, Mitsumasa</creator><creator>Shimomura, Iichiro</creator><creator>Masuyama, Tohru</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201011</creationdate><title>Decrease in Serum Adiponectin Levels in Response to Treatment Predicts Good Prognosis in Acute Decompensated Heart Failure</title><author>Matsumoto, Mika ; Lee‐Kawabata, Masaaki ; Tsujino, Takeshi ; Naito, Yoshiro ; Ezumi, Akira ; Sakoda, Tsuyoshi ; Ohyanagi, Mitsumasa ; Shimomura, Iichiro ; Masuyama, Tohru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5388-b0d584a9f82517de33f8186ab5bad0f572aad894edf7d5260753717bf35a2b3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acute Disease</topic><topic>Adiponectin - blood</topic><topic>Adipose Tissue - drug effects</topic><topic>Adipose Tissue - metabolism</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - metabolism</topic><topic>Heart Failure - physiopathology</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Original Papers</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsumoto, Mika</creatorcontrib><creatorcontrib>Lee‐Kawabata, Masaaki</creatorcontrib><creatorcontrib>Tsujino, Takeshi</creatorcontrib><creatorcontrib>Naito, Yoshiro</creatorcontrib><creatorcontrib>Ezumi, Akira</creatorcontrib><creatorcontrib>Sakoda, Tsuyoshi</creatorcontrib><creatorcontrib>Ohyanagi, Mitsumasa</creatorcontrib><creatorcontrib>Shimomura, Iichiro</creatorcontrib><creatorcontrib>Masuyama, Tohru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of clinical hypertension (Greenwich, Conn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsumoto, Mika</au><au>Lee‐Kawabata, Masaaki</au><au>Tsujino, Takeshi</au><au>Naito, Yoshiro</au><au>Ezumi, Akira</au><au>Sakoda, Tsuyoshi</au><au>Ohyanagi, Mitsumasa</au><au>Shimomura, Iichiro</au><au>Masuyama, Tohru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decrease in Serum Adiponectin Levels in Response to Treatment Predicts Good Prognosis in Acute Decompensated Heart Failure</atitle><jtitle>The journal of clinical hypertension (Greenwich, Conn.)</jtitle><addtitle>J Clin Hypertens (Greenwich)</addtitle><date>2010-11</date><risdate>2010</risdate><volume>12</volume><issue>11</issue><spage>900</spage><epage>904</epage><pages>900-904</pages><issn>1524-6175</issn><eissn>1751-7176</eissn><abstract>J Clin Hypertens (Greenwich). Adiponectin is a cardioprotective adipocytokine. Serum adiponectin concentration decreases in patients who are obese but increases in patients with chronic heart failure (CHF). The aim of this study was to explore the temporal changes in serum adiponectin concentration following treatment for acute decompensated heart failure (ADHF). Serum adiponectin was measured on admission and at discharge in 95 patients who were admitted to our hospital with ADHF. Ten patients without heart failure (HF) served as controls. Serum adiponectin concentration was higher on admission in HF patients than in the controls (22.6±13.3 μg/mL vs 9.3±3.9 μg/mL, P&lt;.01). Serum adiponectin concentration decreased after treatment in HF patients (18.0±11.7 μg/mL vs 22.6±13.3 μg/mL, P&lt;.01). The larger temporal decrease in adiponectin level in ADHF was associated with the lower incidence of cardiac death or HF hospitalizations (log‐rank, P&lt;.05). Serum adiponectin concentration was elevated in ADHF and decreased following the treatment. How much serum adiponectin decreases in response to treatment in ADHF is an important determinant of the prognosis. J Clin Hypertens (Greenwich). 2010;12:900–904.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21054778</pmid><doi>10.1111/j.1751-7176.2010.00368.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1524-6175
ispartof The journal of clinical hypertension (Greenwich, Conn.), 2010-11, Vol.12 (11), p.900-904
issn 1524-6175
1751-7176
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8816472
source PubMed Central
subjects Acute Disease
Adiponectin - blood
Adipose Tissue - drug effects
Adipose Tissue - metabolism
Aged
Aged, 80 and over
Female
Follow-Up Studies
Heart Failure - drug therapy
Heart Failure - metabolism
Heart Failure - physiopathology
Hospitalization
Humans
Male
Middle Aged
Mortality
Original Papers
Predictive Value of Tests
Prognosis
title Decrease in Serum Adiponectin Levels in Response to Treatment Predicts Good Prognosis in Acute Decompensated Heart Failure
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T16%3A53%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decrease%20in%20Serum%20Adiponectin%20Levels%20in%20Response%20to%20Treatment%20Predicts%20Good%20Prognosis%20in%20Acute%20Decompensated%20Heart%20Failure&rft.jtitle=The%20journal%20of%20clinical%20hypertension%20(Greenwich,%20Conn.)&rft.au=Matsumoto,%20Mika&rft.date=2010-11&rft.volume=12&rft.issue=11&rft.spage=900&rft.epage=904&rft.pages=900-904&rft.issn=1524-6175&rft.eissn=1751-7176&rft_id=info:doi/10.1111/j.1751-7176.2010.00368.x&rft_dat=%3Cproquest_pubme%3E763176342%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5388-b0d584a9f82517de33f8186ab5bad0f572aad894edf7d5260753717bf35a2b3c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=763176342&rft_id=info:pmid/21054778&rfr_iscdi=true